Actualité du CIRC
IARC Monographs Volume 110: Perfluorooctanoic Acid, Tetrafluoroethylene, Dichloromethane, 1,2-Dichloropropane, and 1,3-Propane Sultone
20/07/2016 The International Agency for Research on Cancer (IARC) is pleased to announce that the Monograph on Perfluorooctanoic Acid (PFOA) is now available online. The remaining Monographs of Volume 110 will be published subsequently. Visit the Volume 110 webpage
07/07/2016 The International Agency for Research on Cancer (IARC) is pleased to announce that a gallery of photographs from the IARC 50th anniversary scientific conference, “Global Cancer: Occurrence, Causes, and Avenues to Prevention”, held in Lyon on 7–10 June 2016, is now available. View gallery
A new study, published in The American Journal of Clinical Nutrition, shows that the highest levels of blood selenium or of selenoprotein P, the protein that distributes selenium from the liver around the body, are associated with a decreased risk of developing liver cancer (particularly hepatocellular carcinoma), even when all other major liver cancer risk factors are taken into account.
Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
Hughes DJ, Duarte-Salles T, Hybsier S, Trichopoulou A, Stepien M, Aleksandrova K, et al.
Am J Clin Nutr. Published Online 29 June 2016; http://dx.doi.org/10.3945/ajcn.116.131672
Lire article, Lire Communiqué de presse N°245
Communiqués de presse
IARC Handbook of Cancer Prevention Volume 15
Breast Cancer Screening
A Working Group of 29 independent experts from 16 countries, convened by the International Agency for Research on Cancer (IARC) in November 2014, reviewed the scientific evidence and assessed the cancer-preventive and adverse effects of various methods of screening for breast cancer. This publication provides an important update of the landmark 2002 IARC Handbook on Breast Cancer Screening, in light of recent improvements in treatment outcomes for late-stage breast cancer and recent data on the effectiveness of organized screening programmes. The Working Group also considered non-mammographic imaging techniques, clinical breast examination, and breast self-examination.
MORTALITY AND PREVALENCE
WORLDWIDE IN 2012